About: Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.33 (+1.53%)
ALZN NASDAQ Alzamend Neuro Inc
Alzamend Neuro Inc share price
ALZN price activity
Last Price
$1.330
Change (24hr)
0.02 USD (1.53%)
Volume
8.40K
Volume (4w avg)
-
Open
$1.43
Day Range
$1.31 - $1.43
Previous Close
$1.31
Last Trade
13 Oct, 5:27 pm GMT+0
Delayed
13 Oct, 5:27 pm GMT+0
ALZN price performance
Delayed
13 Oct, 5:27 pm GMT+0
ALZN Market Signals